Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Alector	Regenxbio	Fate Therapeutics	Cortexyme	Denali Therapeutics
Symbol	NASDAQ:ALEC	NASDAQ:RGNX	NASDAQ:FATE	NASDAQ:CRTX	NASDAQ:DNLI
Price Information
Current Price	$23.94	$30.84	$24.61	$39.54	$18.74
52 Week Range	Buy	Buy	Buy	Hold	Buy
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Hold	Buy
Consensus Price Target	$28.00	$76.75	$35.44	$34.25	$29.67
% Upside from Price Target	16.96% upside	148.87% upside	44.00% upside	-13.38% downside	58.31% upside
Trade Information
Market Cap	$1.84 billion	$1.16 billion	$1.74 billion	$1.03 billion	$2.03 billion
Beta	1.24	1.04	1.8	N/A	1.8
Average Volume	574,707	685,643	1,563,486	151,254	667,759
Sales & Book Value
Annual Revenue	$21.22 million	$35.23 million	$10.68 million	N/A	$26.68 million
Price / Sales	88.60	32.51	174.99	N/A	74.05
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$2.83 per share	$12.23 per share	$3.24 per share	$4.30 per share	$4.11 per share
Price / Book	8.46	2.52	7.60	N/A	4.56
Profitability
Net Income	$-105,390,000.00	$-94,730,000.00	$-98,150,000.00	$-36,980,000.00	$-197,610,000.00
EPS	($1.71)	($3.26)	($1.44)	($1.94)	($2.07)
Trailing P/E Ratio	N/A	N/A	N/A	N/A	N/A
Forward P/E Ratio	N/A	N/A	N/A	∞	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-496.65%	-268.88%	-919.00%	N/A	-740.74%
Return on Equity (ROE)	-45.56%	-25.21%	-49.94%	-43.38%	-43.31%
Return on Assets (ROA)	-22.85%	-23.31%	-36.92%	-31.36%	-32.00%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.21%	0.02%	0.10%	N/A	0.17%
Current Ratio	5.77%	10.25%	8.17%	11.93%	9.48%
Quick Ratio	5.77%	10.25%	8.17%	11.93%	9.48%
Ownership Information
Institutional Ownership Percentage	53.54%	80.84%	95.07%	27.03%	67.08%
Insider Ownership Percentage	13.90%	13.80%	21.41%	N/A	21.20%
Miscellaneous
Employees	91	192	104	16	179
Shares Outstanding	78.53 million	37.14 million	75.94 million	29.40 million	105.42 million
Next Earnings Date	5/11/2020 (Estimated)	5/5/2020 (Estimated)	5/5/2020 (Estimated)	6/10/2020 (Estimated)	5/13/2020 (Estimated)
Optionable	Not Optionable	Optionable	Optionable	Not Optionable	Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources